ENTITY
WuXi AppTec

WuXi AppTec (2359 HK)

622
Analysis
Health Care • China
WuXi AppTec is a global contract research, development, and manufacturing organization (CRDMO) for the pharmaceutical and life sciences industries. It provides integrated, end-to-end services including chemistry drug CRDMO, biology discovery, preclinical testing, and clinical research services for various therapeutic modalities. The company was founded in 2000 and is headquartered in Shanghai, China.
more
Exchange Announcement • 12 Oct 2026 16:32

Date Of Board Meeting

Exchange Announcement • 29 Sep 2026 22:46

Articles Of Association

Exchange Announcement • 29 Sep 2026 17:40

(1) Poll Results Of The Extraordinary General Meeting; And (2) Amendments To The Articles Of Association

Exchange Announcement • 23 Sep 2026 18:45

Full Conversion And Withdrawal Of Listing Of The Rmb6,780,000,000 U.S. Dollar Settled Zero Coupon Convertible Bonds Due 2027

Exchange Announcement • 23 Sep 2026 16:30

Next Day Disclosure Return

x